Keesler G A, Li Y, Skiba P J, Fless G M, Tabas I
Columbia University College of Physicians and Surgeons, Department of Medicine, New York, NY.
Arterioscler Thromb. 1994 Aug;14(8):1337-45. doi: 10.1161/01.atv.14.8.1337.
Understanding the interaction of the atherogenic lipoprotein, lipoprotein(a) [Lp(a)], with macrophages may provide important insight into the physiology and pathophysiology of this lipoprotein. We have recently shown that cholesterol loading of macrophages, such as occurs in atheroma foam cells, leads to marked upregulation of a novel receptor activity for native Lp(a) and its plasminogen-like protein component, apoprotein(a) [apo(a)]. We show here that the Lp(a)/apo(a) receptor activity on cholesterol-loaded macrophages is trypsin sensitive, indicating that a cell-surface protein is involved and that the upregulation by cholesterol loading requires new protein synthesis. Ligand studies revealed that the foam cell receptor activity recognizes Lp(a) containing both small and large isoforms of apo(a) as well as rhesus monkey Lp(a), which contains an inactive kringle-4(37) (K4(37) lysine-binding domain. Elastase degradation products of plasminogen did not compete for 125I-labeled recombinant apo(a) [125I-r-apo(a)] internalization and degradation by foam cells, indicating that the K4(37) sequence, as well as the K5 and "protease" domains of apo(a), are not sufficient for receptor interaction. Consistent with these data, the degradation of 125I-r-apo(a) was completely blocked by an anti-Lp(a) polyclonal antibody that does not cross-react with plasminogen. Furthermore, the multiple sialic residues of apo(a) are also not involved in receptor interaction, since desialylated r-apo(a) interacted with foam cells as well as native r-apo(a). In contrast, reduced and denatured r-apo(a) was degraded by foam cells only slightly better than by control cells [28% increased degradation by foam cells versus 450% for native r-apo(a)], suggesting that the upregulated receptor activity recognizes certain secondary and tertiary structural features of apo(a).(ABSTRACT TRUNCATED AT 250 WORDS)
了解致动脉粥样硬化脂蛋白脂蛋白(a)[Lp(a)]与巨噬细胞的相互作用,可能为深入了解这种脂蛋白的生理和病理生理学提供重要线索。我们最近发现,巨噬细胞的胆固醇负荷,如动脉粥样硬化泡沫细胞中发生的情况,会导致对天然Lp(a)及其纤溶酶原样蛋白成分载脂蛋白(a)[apo(a)]的一种新型受体活性显著上调。我们在此表明,胆固醇负荷巨噬细胞上的Lp(a)/apo(a)受体活性对胰蛋白酶敏感,这表明涉及一种细胞表面蛋白,并且胆固醇负荷引起的上调需要新的蛋白质合成。配体研究表明,泡沫细胞受体活性识别含有小和大同工型apo(a)的Lp(a)以及恒河猴Lp(a),后者含有无活性的kringle-4(37)(K4(37)赖氨酸结合结构域)。纤溶酶原的弹性蛋白酶降解产物不竞争泡沫细胞对125I标记的重组apo(a)[125I-r-apo(a)]的内化和降解,这表明K4(37)序列以及apo(a)的K5和“蛋白酶”结构域不足以进行受体相互作用。与这些数据一致,125I-r-apo(a)的降解被一种不与纤溶酶原交叉反应的抗Lp(a)多克隆抗体完全阻断。此外,apo(a)的多个唾液酸残基也不参与受体相互作用,因为去唾液酸化的r-apo(a)与泡沫细胞的相互作用与天然r-apo(a)一样。相比之下,还原和变性的r-apo(a)被泡沫细胞降解的程度仅略高于对照细胞[泡沫细胞降解增加28%,而天然r-apo(a)为450%],这表明上调的受体活性识别apo(a)的某些二级和三级结构特征。(摘要截短于250字)